[A comparative trial of bronchodilator effects of fenoteral and sch 1000 in chronic bronchitis (author's transl)]
- PMID: 797410
[A comparative trial of bronchodilator effects of fenoteral and sch 1000 in chronic bronchitis (author's transl)]
Abstract
In a group of 20 patients with chronic bronchitis, bronchodilator effects of fenoterol (400 mug), SCH 1000 (40 mug), and their combination (fenoterol 400 mug msch 1000 40 mug) have been evaluated and compared by measuring total pulmonary capacity (CPT), intrthoracic gas volume (VGT), forced expiratory volume in one second (VEMS), specific airways resistance (SRva) and maximun expiratory flow at a lung volume for which the initial flow was 0.1 l/s (Vo.iv). Measurements have been made before and 30, 60, 120 and 180 min after administration of the drug. With each of the three drugs, the improvement of the five functional parameters is statistically significant at all time intervals. Changes in CPT, VGT, VEMS and SRva are not statistically different when using the different drugs, whereas the Vo.1v changes suggest a lesser bronchodilator effect of SCH 1000 than fenoterol (p less than 0.05 at 180 min), and especially than fenoterol-SCH 1000 combination (p less than 0.05 at all time intervals). The combination is lightly but not significantly better than fenoterol only. On account of these results and the very high tolerance for the two drugs, a new medication combining SCH 1000 and fenoterol is desirable. The authors emphasize the sensitivity of maximum expiratory flow measurements at low lung volumes for trials on bronchodilators and the necessity to consider the possible reduction in CPT for flows comparison at an identical absolute lung volume.
Similar articles
-
Bronchodilatory and circulatory effects of inhaling increasing doses of an anti-cholinergic drug, ipratropium bromide (SCH 1000).Scand J Respir Dis. 1975 Sep;56(3):138-49. Scand J Respir Dis. 1975. PMID: 1162305
-
[Comparative study of the bronchodilating effect of SCH 1000, berotec and of the association of the two drugs in patients with spastic bronchitis (author's transl)].Acta Tuberc Pneumol Belg. 1974 Sep-Oct;65(5):534-9. Acta Tuberc Pneumol Belg. 1974. PMID: 4282820 Clinical Trial. French. No abstract available.
-
[Can the association of an atropinic (SCH 1000) and a sympathicomimetic improve the bronchodilatation obtained by a sympathicomimetic alone (author's transl)].Acta Tuberc Pneumol Belg. 1974 May-Aug;65(3-4):395-408. Acta Tuberc Pneumol Belg. 1974. PMID: 4282560 Clinical Trial. French. No abstract available.
-
[Combined administration of ipratropium bromide (sch 1000) and fenoterol in patients with chronic obstructive airway disease (author's transl)].Wien Klin Wochenschr. 1975 Oct 17;87(19):653-6. Wien Klin Wochenschr. 1975. PMID: 132015 German.
-
[Clinical testing of bronchospasmolytics in combined alternating test schedules].Int J Clin Pharmacol Biopharm. 1976 Mar;13(2):97-106. Int J Clin Pharmacol Biopharm. 1976. PMID: 3472 Clinical Trial. German.
Cited by
-
Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis.Drugs. 1980 Oct;20(4):237-66. doi: 10.2165/00003495-198020040-00001. Drugs. 1980. PMID: 6448137 Review.
-
Fenoterol: a review of its pharmacological properties and therapeutic efficacy in asthma.Drugs. 1978 Jan;15(1):3-32. doi: 10.2165/00003495-197815010-00002. Drugs. 1978. PMID: 342228 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous